Srinivasa Reddy (Founder & COO) Sharing Importance & Clinical Evidence Supporting Microdosing Psilocybin Assisted Therapy

Cube Psytech Corp. founder and COO will be proudly presenting the scientific evidence of microdosing its clinical background at Psychedelics Medicine Tour 2022, Dallas, TX, USA. 

Use of psilocybin containing mushrooms is not new around the globe. But need of optimised dosages and to prove its importance through clinical evidence, it is vital to emerge the findings to treat mental health. Microdosing has been significant part of psilocybin assisted therapy for mental health. Increasing demand for the therapy also requires a proof of studies as evidence of positive or negative impacts. Cube Psytech Corp. founder and COO will be proudly presenting the scientific evidence of microdosing its clinical background at Psychedelics Medicine Tour 2022, Dallas, TX, USA. https://www.psychedelicmedicineconference.net

It was also an honor that our Founder and COO, Srinivasa Reddy proudly shared his experience and knowledge of psilocybin as medicine past-present and future at GROWUP PSYCHEDELIC SUMMIT held in Scotia Bank Convention center, Niagara, ON.